Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO)
Primary Objective
The proposed pilot trial seeks to establish the impact of GLP-1RA as an adjunctive cardiorenal therapy in optimally managed T1D, to improve cardiovascular, kidney and metabolic function in young adults with T1D.
Details
Age
Adult
Type of Study
Treatment
Scope
Local
Locations
Anschutz Health and Wellness
Barbara Davis Center
Brain Imaging Center (BIC)
CTRC Inpatient
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Petter Bjornstad, MD
Study ID
Protocol Number: 22-0794
More information available at ClinicalTrials.gov: NCT05819138
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers